Hybrid Conferencee

International Conference on Cardiac Biomarkers and Personalized Medicine (ICCBPM - 26)

18th - 19th August 2026 | Espoo, Finland

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Espoo. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Espoo event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Espoo conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Espoo, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Espoo."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Innovations in Cardiac Biomarker Discovery

This track focuses on the latest advancements in the identification and validation of cardiac biomarkers. Researchers will present novel methodologies and technologies that enhance biomarker discovery for cardiovascular diseases.

Track 02

Precision Medicine in Cardiology

This session explores the integration of precision medicine approaches in the management of cardiovascular diseases. Discussions will highlight personalized treatment strategies based on genetic, environmental, and lifestyle factors.

Track 03

Translational Research in Cardiovascular Medicine

This track emphasizes the translation of basic research findings into clinical applications in cardiology. Participants will examine successful case studies and innovative strategies that bridge the gap between laboratory and bedside.

Track 04

Clinical Applications of Cardiac Biomarkers

This session will address the clinical utility of various cardiac biomarkers in diagnosing and managing heart disease. Experts will share insights on how biomarkers can improve patient outcomes and guide therapeutic decisions.

Track 05

Emerging Technologies in Cardiovascular Diagnostics

This track will showcase cutting-edge technologies that enhance cardiovascular diagnostics. Presentations will cover advancements in imaging, wearable devices, and laboratory techniques that facilitate early detection and monitoring.

Track 06

Heart Disease Epidemiology and Risk Stratification

This session will delve into the epidemiological trends of heart disease and the role of biomarkers in risk stratification. Researchers will discuss population-based studies and their implications for public health.

Track 07

Biomarkers in Heart Failure Management

This track focuses on the role of biomarkers in the diagnosis and management of heart failure. Experts will discuss how biomarkers can inform treatment decisions and predict patient outcomes.

Track 08

Cardiovascular Pharmacogenomics

This session will explore the impact of pharmacogenomics on cardiovascular drug therapy. Discussions will focus on how genetic variations influence drug response and the implications for personalized treatment.

Track 09

Integrative Approaches in Cardiovascular Health

This track highlights integrative approaches combining lifestyle interventions with biomarker-guided therapies. Participants will explore the synergy between traditional and complementary medicine in promoting cardiovascular health.

Track 10

Regulatory Perspectives on Cardiovascular Biomarkers

This session will provide insights into the regulatory landscape surrounding the development and approval of cardiovascular biomarkers. Experts will discuss challenges and opportunities in bringing biomarkers to clinical practice.

Track 11

Future Directions in Cardiovascular Research

This track will focus on emerging trends and future directions in cardiovascular research, particularly in the context of biomarkers and personalized medicine. Participants will engage in discussions about innovative research avenues and collaborative opportunities.